Product Information
EZETIMIBE-SIMVASTATIN 10-20 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2278 per EA under NDC 68462032290. Its NADAC has been published 334 times since Apr 1, 2020.
FDA first approved this application on Jun 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 20 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462032290
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208699FDA Approved
6/27/2019
TE Code
AB
On Market Since
6/27/2019
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has been published 334 times since Apr 1, 2020, and over the history we have for it it has declined 86.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2278 per EA |
|---|---|
| All-time high | $1.6817 (Apr 15, 2020) |
| All-time low | $0.2278 (Aug 19, 2026) |
| 52-week high | $0.4025 |
| 52-week low | $0.2278 |
| Median price | $0.4375 |
| Average price | $0.6101 |
| Largest weekly change | +46.7% (Jun 19, 2024) |
| Weeks tracked | 334 |
| Tracking since | Apr 1, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-20 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2278 per EA (NDC 68462032290), effective Aug 19, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-20 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has declined 86.5%. It has been tracked across 334 weekly CMS publications since Apr 1, 2020.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-20 MG?
Since Apr 1, 2020, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has ranged from a low of $0.2278 (Aug 19, 2026) to a high of $1.6817 (Apr 15, 2020), with a median of $0.4375 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-20 MG?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EZETIMIBE-SIMVASTATIN 10-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures EZETIMIBE-SIMVASTATIN 10-20 MG?
EZETIMIBE-SIMVASTATIN 10-20 MG (NDC 68462032290) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.